Renal transplants with delayed graft function show decreased renal function despite monitoring with postabsorptive levels

Transplantation Proceedings

Volumn 36, Issue 6, 2004, Pages 1655-1658

  Dominguez, J ^a,b,c   Gonzalez, A ^a,b   Crossley, N ^a,b   Norambuena, R ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL DR SÓTERO DEL RÍO   (Chile)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; PREDNISONE; RAPAMYCIN;

ACUTE GRAFT REJECTION; CADAVER DONOR; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FOLLOW UP; HUMAN; INCIDENCE; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; MONITORING; PRIORITY JOURNAL; RECIPIENT; SURGICAL PATIENT; TIME;

CREATININE; CYCLOSPORINE; DRUG MONITORING; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; RETROSPECTIVE STUDIES;

EID: 4444314612     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.06.015     Document Type: Conference Paper

References (15)

1. B.D. Kahan, J. Dunn, C Fitts Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals Transplantation 59 1995 505
2. A. Lindholm, B.D. Kahan Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation Clin Pharmacol Ther 54 1993 205
3. P. Belitsky, G.A. Levy, A. Johnston Neoral absorption profiling an evolution in effectiveness Transplant Proc 32 3A 2000 45S
4. K. Mahalati, P. Belitsky, I Sketris Neoral monitoring by simplified sparse sampling area under the concentration-time curve its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation Transplantation 68 1999 55
5. K. Mahalati, J. Lawen, B Kiberd Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period? J Urol 163 2000 37
6. J. Dominguez, A. Tomic, R. Norambuena Three-hour postdose cyclosporine level monitoring less rejection and more nephrotoxicity? Transplant Proc 33 2001 3120
7. K. Mahalati, J. Lawen, B Kiberd Improved recovery from DGF in Neoral treated renal transplant recipients monitored by absorption profiling versus trough levels Am J Transplant 1(S1) 2001 406
8. M. Cantarovich, E. Elstein, B de Varennes Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients Transplantation 68 1999 1839
9. G.A. Levy Neoral C(2) in liver transplant recipients Transplant Proc 33 2001 3089
10. A. Barama, S. Yilmaz, J Gough Correlation between Cyclosporine pharmacokinetic parameters and acute histological findings in surveillance biopsies Am J Transplant 1(S1) 2001 192
11. M.C. Rial, S. Frias, J Argento Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant Transplant Proc 29 1997 292
12. M. Rial Impact of level of Cyclosporine neoral at time 3 (T3) on kidney graft function A transplant odyssey S20.1 2001 142
13. E. Thervet, P. Pfeffer, M.P Scolari Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion Transplantation 76 2003 903
14. J. Dominguez, P. Troncoso, L Martinez Impacto de la Ciclosporina en el dao renal por isquemia reperfusion Rev Chil Uro 62 1997 47
15. S.R. Inman, N.A. Davis, K.M Olson Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury Urology 62 2003 750